Wrap up of 2023 for Biotherapy Partners

January is a good time to reflect on the past year for Biotherapy Partners.
In 2023, we contributed to 19 projects for 11 companies to help them advance their Biological Drug Development programs.
These projects encompassed: Biologicals, genetherapy, celltherapy, for strategic and/or operational drug development, due diligence or trainings.
Biotherapy Partners contributed to 1 CTA filing for a new CAR T program and 1 IMPD for a biological.
We also launched our website!  Please visit Home – Biotherapy Partners
We look forward to continuing developing Drugs in 2024 through our consulting activities! Do not hesitate to contact us at contact@biotherapypartners.com